Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

toothbrush

- PMLiVE

Kidney Research UK invests in Healthinote patient education platform which could support >15m people with long term health conditions

Kidney Research UK, the leading charity dedicated to kidney health, has made a significant investment in Cognitant Group Ltd, a leading provider of digital education and support tools to improve...

Healthinote (by Cognitant)

- PMLiVE

Health literacy & the creation of shared decision aids for patients with cancer

In this blog, Gini Melesi, Head of Transformation, East of England Cancer Alliance, & Diane Whitney, Head of Brachytherapy Physics, Cambridge University Hospitals NHS Foundation Trust, explore the relationship between...

Healthinote (by Cognitant)

- PMLiVE

Being Rare Together: Medscape Education Sponsors the 2025 Cholestatic Liver Disease Summit

Medscape Education is a proud sponsor of the inaugural 2025 Cholestatic Liver Disease Summit, taking place June 26–28 in Aurora, Colorado, at the Hyatt Regency Aurora-Denver Conference Center. Hosted in...

Medscape Education

- PMLiVE

Gilead Sciences and Kymera enter oncology partnership worth up to $750m

The companies will focus on advancing Kymera’s oral molecular glue degrader programme

- PMLiVE

MHRA approves Accord Healthcare’s Hetronifly to treat aggressive form of lung cancer

Small cell lung cancer accounts for up to 15% of all lung cancer diagnoses

- PMLiVE

Ipsen receives CHMP recommendation for Cabometyx in neuroendocrine tumours

The number of patients newly diagnosed with NETs is believed to be on the rise

- PMLiVE

The Considered appoints Emily Knight-Kristoffersen as chief creative officer

Knight-Kristoffersen most recently served as the agency’s executive vice president, creative director

- PMLiVE

More than digital: prioritising the human element in HCP engagement design

By Steph Wasek

- PMLiVE

MHRA becomes founding member of HealthAI Global Regulatory Network

The network of health regulators will focus on the safe and effective use of AI in healthcare

- PMLiVE

J&J’s Darzalex recommended by CHMP to treat smouldering multiple myeloma

If approved, Darzalex would be the first therapy approved in the EU for SMM

- PMLiVE

New Alzheimer’s Treatments Are Driving a Shift in Earlier Detection and Clinician Education Engagement

June is Brain and Alzheimer’s Awareness Month — a chance to examine real-world data that links new treatments to changing clinical behavior.

Medscape Education

EU flag

EC approves argenx’s subcutaneous Vyvgart for rare autoimmune disease CIPD

The drug has been authorised as a monotherapy for adults with progressive or relapsing active cases

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links